| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accessing palliative care for multiple sclerosis: A qualitative study of a neglected neurological disease
|
Cheong, Wing Loong
|
|
2019
|
35 |
C |
p. 86-91
|
artikel
|
| 2 |
Adaptation to repeated gait-slip perturbations among individuals with multiple sclerosis
|
Yang, Feng
|
|
2019
|
35 |
C |
p. 135-141
|
artikel
|
| 3 |
AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review
|
Tao, Shuxin
|
|
2019
|
35 |
C |
p. 185-192
|
artikel
|
| 4 |
A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children
|
Manguinao, Michael
|
|
2019
|
35 |
C |
p. 50-54
|
artikel
|
| 5 |
A special association between Charcot-Marie-Tooth type 1A disease and relapsing remitting multiple sclerosis
|
Doğan, Yahya
|
|
2019
|
35 |
C |
p. 83-85
|
artikel
|
| 6 |
A unique case of multiphasic ADEM or what else?
|
Losavio, Francesco Antonio
|
|
2019
|
35 |
C |
p. 73-75
|
artikel
|
| 7 |
B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis
|
Massey, Jennifer
|
|
2019
|
35 |
C |
p. 100-103
|
artikel
|
| 8 |
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
|
Gaetani, Lorenzo
|
|
2019
|
35 |
C |
p. 228-232
|
artikel
|
| 9 |
Changing patterns of multiple sclerosis in Korea: Toward a more baseline MRI lesions and intrathecal humoral immune responses
|
Shin, Hyun-June
|
|
2019
|
35 |
C |
p. 209-214
|
artikel
|
| 10 |
Circulating mesenchymal stem cells, stromal derived factor (SDF)-1 and IP-10 levels increased in clinically active multiple sclerosis patients but not in clinically stable patients treated with beta interferon
|
Emamnejad, Rahimeh
|
|
2019
|
35 |
C |
p. 233-238
|
artikel
|
| 11 |
Cognitive and brain reserve in multiple sclerosis––A cross-sectional study
|
Ifantopoulou, Parthena
|
|
2019
|
35 |
C |
p. 128-134
|
artikel
|
| 12 |
Construct validity and test–retest reliability of the Swedish version of the Acceptance of Chronic Health Conditions Scale
|
Wallin, Andreas
|
|
2019
|
35 |
C |
p. 203-208
|
artikel
|
| 13 |
Continuous 12 min walking to music, metronomes and in silence: Auditory-motor coupling and its effects on perceived fatigue, motivation and gait in persons with multiple sclerosis
|
Moumdjian, Lousin
|
|
2019
|
35 |
C |
p. 92-99
|
artikel
|
| 14 |
[11C]PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis
|
Carvalho, Robert H.F.
|
|
2019
|
35 |
C |
p. 108-115
|
artikel
|
| 15 |
Cytomegalovirus primary infection in a patient with multiple sclerosis treated with alemtuzumab
|
Aguirre, Clara
|
|
2019
|
35 |
C |
p. 270-271
|
artikel
|
| 16 |
Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study
|
Schmidt, Stephan
|
|
2019
|
35 |
C |
p. 262-269
|
artikel
|
| 17 |
Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)
|
Matza, Louis S.
|
|
2019
|
35 |
C |
p. 253-261
|
artikel
|
| 18 |
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes
|
Yano, Hajime
|
|
2019
|
35 |
C |
p. 119-127
|
artikel
|
| 19 |
Effectiveness and tolerability of immunosuppressants and monoclonal antibodies in preventive treatment of neuromyelitis optica spectrum disorders: A systematic review and network meta-analysis
|
Huang, Wenjuan
|
|
2019
|
35 |
C |
p. 246-252
|
artikel
|
| 20 |
Grassroot efforts towards diversity in MS care and research: Win-win for patients and science
|
Waubant, Emmanuelle
|
|
2019
|
35 |
C |
p. A1-A2
|
artikel
|
| 21 |
Higher health care use before a clinically isolated syndrome with or without subsequent MS
|
Marrie, Ruth Ann
|
|
2019
|
35 |
C |
p. 42-49
|
artikel
|
| 22 |
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
|
Horakova, D.
|
|
2019
|
35 |
C |
p. 196-202
|
artikel
|
| 23 |
Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: A case report
|
Mizuno, Yuri
|
|
2019
|
35 |
C |
p. 16-18
|
artikel
|
| 24 |
Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis
|
Silsby, Matthew
|
|
2019
|
35 |
C |
p. 104-107
|
artikel
|
| 25 |
Lymphocytes B population profile in a case of multiple sclerosis presenting with sudden sensorineural hearing loss caused by a demyelinating pontine lesion
|
Dulamea, Adriana Octaviana
|
|
2019
|
35 |
C |
p. 170-175
|
artikel
|
| 26 |
MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis
|
Fattahi, Mahtab
|
|
2019
|
35 |
C |
p. 241-245
|
artikel
|
| 27 |
Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis
|
Rooney, Scott
|
|
2019
|
35 |
C |
p. 158-163
|
artikel
|
| 28 |
Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study
|
Hegedüs, Katalin
|
|
2019
|
35 |
C |
p. 150-155
|
artikel
|
| 29 |
Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialities
|
Jongen, Peter Joseph
|
|
2019
|
35 |
C |
p. 142-149
|
artikel
|
| 30 |
Patients’ preferences and willingness-to-pay for disease-modifying therapies
|
Frost, Natasha
|
|
2019
|
35 |
C |
p. 55-60
|
artikel
|
| 31 |
Physical activity and walking performance across the lifespan among adults with multiple sclerosis
|
Baird, Jessica F.
|
|
2019
|
35 |
C |
p. 36-41
|
artikel
|
| 32 |
Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis
|
Baker, David
|
|
2019
|
35 |
C |
p. 19-25
|
artikel
|
| 33 |
Pulmonary embolism during the third cycle of alemtuzumab in a patient with relapsing multiple sclerosis
|
Habek, Mario
|
|
2019
|
35 |
C |
p. 5-6
|
artikel
|
| 34 |
Rash developing after cessation of Daclizumab for relapsing remitting MS; a case series
|
Lockhart, Andrew
|
|
2019
|
35 |
C |
p. 239-240
|
artikel
|
| 35 |
Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report
|
Aoe, Shingo
|
|
2019
|
35 |
C |
p. 182-184
|
artikel
|
| 36 |
Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS
|
Breza, Marianthi
|
|
2019
|
35 |
C |
p. 156-157
|
artikel
|
| 37 |
Risk of cancer among Finnish multiple sclerosis patients
|
Hongell, Kira
|
|
2019
|
35 |
C |
p. 221-227
|
artikel
|
| 38 |
Safety outcomes of disease-modifying therapies for relapsing–remitting multiple sclerosis: A network meta-analysis
|
Lucchetta, Rosa C
|
|
2019
|
35 |
C |
p. 7-15
|
artikel
|
| 39 |
Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases
|
Cortese, Antonio
|
|
2019
|
35 |
C |
p. 193-195
|
artikel
|
| 40 |
Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS
|
Lopez-Chiriboga, Sebastian
|
|
2019
|
35 |
C |
p. 34-35
|
artikel
|
| 41 |
The clinical spectrum and prognosis of idiopathic acute optic neuritis: A longitudinal study in Southern Finland
|
Siuko, Mika
|
|
2019
|
35 |
C |
p. 215-220
|
artikel
|
| 42 |
The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders
|
Qin, Chuan
|
|
2019
|
35 |
C |
p. 1-4
|
artikel
|
| 43 |
The mediating effect of health-related hardiness on the degree of physical disability and perceived stress in Chinese female patients with neuromyelitis optica spectrum disorder
|
Xu, Yafang
|
|
2019
|
35 |
C |
p. 67-72
|
artikel
|
| 44 |
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience
|
De Fino, C.
|
|
2019
|
35 |
C |
p. 176-181
|
artikel
|
| 45 |
The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse
|
Fitzgerald, Kathryn C.
|
|
2019
|
35 |
C |
p. 61-66
|
artikel
|
| 46 |
Three-week inpatient energy management education (IEME) for persons with multiple sclerosis-related fatigue: Feasibility of a randomized clinical trial
|
Hersche, Ruth
|
|
2019
|
35 |
C |
p. 26-33
|
artikel
|
| 47 |
TREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohort
|
Rikos, Dimitrios
|
|
2019
|
35 |
C |
p. 116-118
|
artikel
|
| 48 |
Unilateral arm rehabilitation for persons with multiple sclerosis using serious games in a virtual reality approach: Bilateral treatment effect?
|
Jonsdottir, Johanna
|
|
2019
|
35 |
C |
p. 76-82
|
artikel
|
| 49 |
Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients
|
Kanikannan, Meena A
|
|
2019
|
35 |
C |
p. 164-169
|
artikel
|
| 50 |
Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis
|
Akatani, Ritsu
|
|
2019
|
35 |
C |
p. 272-275
|
artikel
|
| 51 |
Vitamin D and MRI measures in progressive multiple sclerosis
|
Abbatemarco, Justin R.
|
|
2019
|
35 |
C |
p. 276-282
|
artikel
|
Tijdschrift beschrijving